Sarah Tabrizi, M.D./Ph.D.

Dr. Sarah Tabrizi is an award-winning scientist who has published over 300 peer- reviewed publications, been elected a fellow of the UK Academy of Medical Sciences, co-founded the UCL Huntington’s Disease Centre, and helped set up the UK All-Party Parliamentary Group for Huntington’s disease.

Her complementary research strategies – basic science focusing on cellular mechanisms of neurodegeneration, and a program to translate those findings into treatments and cures – have led to the clinical development of a novel ‘gene silencing’ treatment for Huntington’s disease. Sarah was presented with the Yahr Award, Alexander Morison Medal in 2019, and MRC Millennium Medal and Osler Medal in 2022 for her contributions to research.